ATE286507T1 - Dna kodierend für das strukturalprotein-1 vom infektiösen lachs anämie virus und ihre verwendungen - Google Patents

Dna kodierend für das strukturalprotein-1 vom infektiösen lachs anämie virus und ihre verwendungen

Info

Publication number
ATE286507T1
ATE286507T1 AT00203555T AT00203555T ATE286507T1 AT E286507 T1 ATE286507 T1 AT E286507T1 AT 00203555 T AT00203555 T AT 00203555T AT 00203555 T AT00203555 T AT 00203555T AT E286507 T1 ATE286507 T1 AT E286507T1
Authority
AT
Austria
Prior art keywords
structural protein
dna coding
infectious salmon
anemia virus
protein
Prior art date
Application number
AT00203555T
Other languages
English (en)
Inventor
Erik Biering
Bjorn Krossoy
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8240749&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE286507(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE286507T1 publication Critical patent/ATE286507T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/108—Orthomyxoviridae (F), e.g. influenza virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00203555T 1999-10-18 2000-10-12 Dna kodierend für das strukturalprotein-1 vom infektiösen lachs anämie virus und ihre verwendungen ATE286507T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99203401 1999-10-18

Publications (1)

Publication Number Publication Date
ATE286507T1 true ATE286507T1 (de) 2005-01-15

Family

ID=8240749

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00203555T ATE286507T1 (de) 1999-10-18 2000-10-12 Dna kodierend für das strukturalprotein-1 vom infektiösen lachs anämie virus und ihre verwendungen

Country Status (10)

Country Link
US (1) US6471964B1 (de)
EP (1) EP1094069B2 (de)
JP (1) JP4777508B2 (de)
AT (1) ATE286507T1 (de)
AU (1) AU778791B2 (de)
CA (1) CA2321437A1 (de)
DE (1) DE60017229D1 (de)
DK (1) DK1094069T4 (de)
NO (1) NO330866B1 (de)
NZ (1) NZ507530A (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1637614A3 (de) 1999-08-07 2006-11-29 Novartis AG Nukleinsäure und Antikörper zum Nachweis von infektiösem Lachsanämievirus
WO2001066569A1 (en) * 2000-03-08 2001-09-13 The University Court Of The University Of Aberdeen Viral antigen and vaccine against isav (infectious salmon anaemia virus)
US20030108901A1 (en) * 2001-07-17 2003-06-12 Kibenge Frederick S.B. Serological test for ISAV in fish
DE60239753D1 (de) 2001-10-19 2011-05-26 Intervet Int Bv Impfstoff gegen infektiöses lachsanämievirus
US7317142B2 (en) 2002-12-13 2008-01-08 Prodi Gene, Inc. Immunization of fish with plant-expressed recombinant proteins
CA2687208C (en) 2006-12-22 2017-02-14 Soluciones Biotecnologicas Innovacion Ltda Process and formulation for immunizing fish in aquaculture systems
WO2011041789A1 (en) 2009-10-02 2011-04-07 The Trustees Of Columbia University In The City Of New York Piscine reovirus immunogenic compositions
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
US12537071B1 (en) 2020-07-22 2026-01-27 David Gordon Bermudes Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1200110A (zh) * 1995-10-18 1998-11-25 拜尔公司 亚氨基乙酰胺类化合物
DE69736163T2 (de) * 1996-11-04 2007-05-03 Ottawa Health Research Institute, Ottawa Verfahren zur Expression von Polypeptide in Fischen durch eintauchen in eine plasmid DNA enthaltende Lösung
JP2002536958A (ja) * 1997-11-21 2002-11-05 ジェンセット Ｃｈｌａｍｙｄｉａｐｎｅｕｍｏｎｉａｅゲノム配列およびポリペプチド、それらのフラグメント、ならびに特に感染症の診断、予防および治療のためのそれらの使用
EP1637614A3 (de) * 1999-08-07 2006-11-29 Novartis AG Nukleinsäure und Antikörper zum Nachweis von infektiösem Lachsanämievirus

Also Published As

Publication number Publication date
EP1094069B2 (de) 2008-04-23
NO20005217D0 (no) 2000-10-17
JP4777508B2 (ja) 2011-09-21
AU6653800A (en) 2001-04-26
DE60017229D1 (de) 2005-02-10
US6471964B1 (en) 2002-10-29
NZ507530A (en) 2001-08-31
EP1094069A1 (de) 2001-04-25
NO330866B1 (no) 2011-08-01
JP2001211888A (ja) 2001-08-07
CA2321437A1 (en) 2001-04-18
AU778791B2 (en) 2004-12-23
EP1094069B1 (de) 2005-01-05
DK1094069T3 (da) 2005-05-17
DK1094069T4 (da) 2008-07-21
NO20005217L (no) 2001-04-19

Similar Documents

Publication Publication Date Title
DE69535061D1 (de) Virale nukleotidsequenz vr-2332 und nutzungsverfahren
CA2005291A1 (en) Feline infectious peritonitis virus diagnostic tools
ATE257175T1 (de) Rekombinantes infektiöses nicht-in-segmente- geteiltes, negativ-strange-rns-virus
ATE26127T1 (de) Rekombinante dna, damit transformierte wirtsorganismen und durch die wirtsorganismen hergestellte polypeptide; verfahren zu ihrer herstellung; nachweisverfahren unter benutzung der polypeptide; die polypeptide enthaltende zusammensetzungen und mittel; dna-sequenzen.
DE69836630D1 (de) Menschliche toll-ähnliche rezeptorproteine, zugehörige reagenzien und verfahren
DE69839557D1 (de) Klonierte genome von infektiösen hepatitis c viren und deren verwendungen
DE60043299D1 (de) Proteinfragmente die polyepitope des nef proteins von hiv umfassen, deren herstellung und verwendungen insbesondere zur impfung
CY1109725T1 (el) Ειδικες δεσμευομενες πρωτεϊνες και χρησεις αυτων
ATE286507T1 (de) Dna kodierend für das strukturalprotein-1 vom infektiösen lachs anämie virus und ihre verwendungen
PT1219711E (pt) Vacina de lawsonia intracellularis
WO2001021807A8 (en) Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof
DE60034884D1 (de) Klonierte genome von infektiösen hepatitis c viren genotyp 2a und deren verwendungen
ATE332712T1 (de) Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe
ATE122055T1 (de) Dna- und rna-moleküle des westlichen subtyps des fsme-virus, polypeptide, die von diesen molekülen codiert werden, und deren verwendung.
WO2001049712A3 (en) Vaccine against isav (infectious salmon anaemia virus)
ATE346087T1 (de) Hepatitis e-virus aus dem schwein und dessen verwendungen
WO2002095413A3 (en) Diagnosis of vascular disease susceptibility using bacteriophage phi-cpn1 host chlamydia
WO1998042847A3 (de) Papillomvirus-hauptcapsid-proteins und deren verwendung in diagnose, therapie und vakzinierung
WO2001036476A3 (en) Ing2, an iaps associated cell cycle protein, compositions and methods of use
WO2002036733A3 (en) Cd36 as a heat shock protein receptor and uses thereof
WO2002026784A3 (en) Matrix proteins m1 and m2 of infections salmon anaemia virus
Simpson et al. Antigenic proteins of Borrelia burgdorferi
Zrein et al. Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 protein of rubella virus
Jackwood et al. Infectious bursal disease virus VP2 fusion protein expressed by baculovirus, use as diagnostic
TH62170A (th) วัคซีนเชื้อก่อโรค Lawsonia intracellularis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties